Stereotactic Body Radiation Therapy (SBRT) in Pelvic Lymph Node Oligometastases.

Abstract:

:The role of stereotactic body radiation therapy (SBRT) in achieving durable local control and palliation of pain in pelvic lymph node oligometastatic disease is not well-studied. We performed a retrospective analysis of 30 patients with 43 pelvic lymph node oligometastases from various primary cancers all but one with non-prostate primaries treated at our institution with SBRT. The median follow-up time was 21 months. The median SBRT dose was 24 Gy in four fractions. The one-, two-, and five-year local control was 74%, 71%, and 70% and one-, two-, and five-year overall survival was 70%, 47%, and 31%. Toxicities were mild with no grade 3 or higher.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Reshko LB,Richardson MK,Spencer K,Kersh CR

doi

10.1080/07357907.2020.1801713

subject

Has Abstract

pub_date

2020-11-01 00:00:00

pages

599-607

issue

10

eissn

0735-7907

issn

1532-4192

journal_volume

38

pub_type

杂志文章
  • Continuous infusion 5-fluorouracil and folinic acid in disseminated colorectal cancer.

    abstract::Twenty-two patients with disseminated adenocarcinoma of the large bowel received therapy with 5-fluorouracil 800-1000 mg/m2 as a 24 h infusion for 4 consecutive days with 60 mg/m2 intravenous folinic acid administered every 6 hours. Major responses were seen in 3 of 20 (15%) evaluable patients, for a median of 5 month...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077039

    authors: Mortimer JE,Higano C

    更新日期:1988-01-01 00:00:00

  • Necrotic lung and bronchopleural fistula as complications of therapy in lung cancer.

    abstract::Seven patients developed a lung abscess and bronchopleural fistula after undergoing aggressive treatment of their lung cancer with radiotherapy +/- chemotherapy. These complications were preceded by a prodrome of recurrent bronchitis with increasing refractoriness to antibiotics, weight loss, fever, and generalized de...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077041

    authors: Frytak S,Lee RE,Pairolero PC,Arnold PG,Shaw JN

    更新日期:1988-01-01 00:00:00

  • Anticarcinogenic effects of shikaron, a preparation of eight Chinese herbs in mice treated with a carcinogen, N-butyl-N'-butanolnitrosoamine.

    abstract::We studied the effects of Shikaron, which is composed of 8 Chinese herb extracts, on carcinogenesis and the cytotoxic activity and cytokine production of lymphocytes in mice treated with a carcinogen, N-butyl-N'-butanolnitrosoamine (BBN). We found a significantly lower incidence of urinary bladder carcinoma in mice tr...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909809050031

    authors: Kurashige S,Jin R,Akuzawa Y,Endo F

    更新日期:1998-01-01 00:00:00

  • Human interleukin 2 gene is located on chromosome 4.

    abstract::The interleukin-2 (IL2) gene is assigned to human chromosome 4. A synthetic oligonucleotide representing bases 285 to 324 of the IL2 cDNA clone described by Taniguchi et al. [Nature (London) 302:305-310, 1983] was used as hybridization probe in Southern blots. Eco RI digests of DNA derived from 11 somatic mouse-human ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908409018440

    authors: Sykora KW,Kolitz J,Szabo P,Grzeschik KH,Moore MA,Mertelsmann R

    更新日期:1984-01-01 00:00:00

  • A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy.

    abstract::This study compared the antiemetic efficacy and safety of two different intravenous (i.v.) dolasetron dosing regimens in patients receiving their first course of high-dose (> or = 80 mg/m2) cisplatin. Of 30 patients enrolled, 14 received a single i.v. dolasetron dose (0.6 mg/kg) before cisplatin and 16 received a mult...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.3109/07357909709039730

    authors: Kasimis BS,Tapazoglou E,Schulman P,Stewart WH,Hahne WF,Cramer MB

    更新日期:1997-01-01 00:00:00

  • Gene expression profile associated with oncogenic ras-induced senescence, cell death, and transforming properties in human cells.

    abstract::We developed inducible and constitutive expression systems of Ha-RasV12 in HEK 293 cells to examine early oncogenic RasV12 signaling. Inducible expression of oncogenic Ras-triggered growth arrest, early senescence, and later apoptosis. Gene expression profile analysis revealed early Ras proliferation and cell cycle ge...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903095623

    authors: Moumtzi SS,Roberts ML,Joyce T,Evangelidou M,Probert L,Frillingos S,Fotsis T,Pintzas A

    更新日期:2010-07-01 00:00:00

  • Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells.

    abstract::Drug resistance to TKIs and the existance of CML leukemia stem cells is an urgent problem. In this study, we demonstrate that quinacrine (QC) induces apoptosis in BCR-ABL positive CML and acute lymphoblastic leukemia (ALL) cells. Interestingly, QC inhibits the colony formation of primary CD34+ progenitor/stem leukemia...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1630633

    authors: Lei H,Tu Y,Yang L,Jin J,Luo H,Xu H,Kang J,Zhou L,Wu Y

    更新日期:2019-01-01 00:00:00

  • Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphoma.

    abstract::The results of a prospective trial with a specifically devised chemotherapy regimen in elderly patients with unfavorable non-Hodgkin's lymphoma (NHL) are reported. Between April 1983 and April 1986, 37 consecutive patients 70 years old or more (median age 80) received etoposide and prednimustine (E + P) 100 mg/m2 p.o....

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909009018923

    authors: Zagonel V,Tirelli U,Carbone A,Errante D,Morassot S,Sorio R,Monfardini S

    更新日期:1990-01-01 00:00:00

  • A phase I trial to determine the safety of imatinib in combination with vatalanib in patients with advanced malignancies.

    abstract::The role of tyrosine kinase inhibitors (TKIs) in the treatment of advanced malignancies is well established. Imatinib and vatalanib are oral TKIs with different mechanisms of action. This trial sought to establish the safety, tolerability, and maximum tolerated dose (MTD) of the two agents in combination. Secondary ob...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.568567

    authors: Spigel D,Jones S,Hainsworth J,Infante J,Greco FA,Thompson D,Doss H,Burris H

    更新日期:2011-05-01 00:00:00

  • Quantitative analysis of tight junctions and the uptake of 99mTc in human gliomas.

    abstract::The structural dimensions of capillary tight junctions and the uptake of 99mTc pertechnetate in human gliomas were studied. Quantitative analysis revealed a correlation between the uptake of radionuclides and the length of endothelial tight junctions. It is suggested that brain scintigraphy might be used for the selec...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609039831

    authors: Nir I,Kohn S,Doron Y,Israel O,Front D

    更新日期:1986-01-01 00:00:00

  • The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.

    abstract::Interstitial collagenase-1 degrades a variety of extracellular matrix components. A single guanine insertion polymorphism in the promoter has been found that influences on the transcription and expression level of the gene. It is suggested that this polymorphism may enhance susceptibility to some types of cancer. Ther...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900801953204

    authors: Kouhkan F,Motovali-Bashi M,Hojati Z

    更新日期:2008-10-01 00:00:00

  • BMP4 is involved in the chemoresistance of myeloid leukemia cells through regulating autophagy-apoptosis balance.

    abstract::This study showed that silencing BMP4 expression significantly activated caspase-2, 3, and 9, while decreasing Matrigel colony formation in Cytarabine (Ara-C)-treated leukemia HL-60 cells. In contrast, Ara-C significantly upregulated Atg5 and Beclin-1 expression, the ratio of LC3-II/LC3-I, and CDK1 and cyclin B1 expre...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.834925

    authors: Zhao X,Liu J,Peng M,Liu J,Chen F

    更新日期:2013-10-01 00:00:00

  • Ab initio studies of some amino acid residue complexes with 4-mercaptopyridine as a model for thymitaq (AG337), an inhibitor of thymidylate synthase.

    abstract::The complex formed by isopentane, as a model for the isoleucine residue present in the wild-type thymidylate synthase, with 4-mercaptopyridine as a fragment of the thymidylate synthase inhibitor Thymitaq (AG337) is investigated with ab initio quantum chemical calculations at Hartree-Fock and MP2 levels, using the 3-21...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909909021431

    authors: Sapse DS,Tong Y,Bertino JR,Sapse AM

    更新日期:1999-01-01 00:00:00

  • Possible Role and Therapeutic Target of PDGF-D Signalling in Colorectal Cancer.

    abstract::Platelet-derived growth factor D (PDGF-D) has been shown to mediate cellular processes of importance in cancer progression. This study aimed to investigate the expression and putative involvement of PDGF-D signaling in colorectal carcinogenesis. PDGF-D was expressed in vascular endothelial cells in tumor and normal ti...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1576191

    authors: Olsen RS,Dimberg J,Geffers R,Wågsäter D

    更新日期:2019-01-01 00:00:00

  • 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.

    abstract::The expression of p53-target genes encoding the proapoptotic factor Noxa, but not PUMA, was not induced by p53 in HCT116 and SW480 cells, which show resistance to apoptosis in response to p53 overexpression. The lack of p53 inducibility of Noxa was restored by treatment with the DNA methyltransferase inhibitor 5-Aza-2...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701840212

    authors: Yagi S,Oda-Sato E,Uehara I,Asano Y,Nakajima W,Takeshita T,Tanaka N

    更新日期:2008-08-01 00:00:00

  • Heterogeneity in TPA-induced differentiation of B-chronic lymphocytic leukemia cells: development of hairy cell or plasmacytoid features are time and dose dependent.

    abstract::Cells from 11 chronic lymphocytic leukemic (CLL) patients were induced to differentiate with various doses of tetradecanoyl phorbol-13-acetate (TPA) and the degree of induction was followed up to six days by measuring the expression of two surface membrane markers (SmIg and GP-70), Ig secretion, tartrate-resistant aci...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:

    authors: Gazitt Y,Gurfel D,Leizerowitz R,Feinstein H,Polliack A

    更新日期:1987-01-01 00:00:00

  • The Roles of Tissue Rigidity and Its Underlying Mechanisms in Promoting Tumor Growth.

    abstract::Tissues become more rigid during tumorigenesis and have been identified as a driving factor for tumor growth. Here, we highlight the concept of tissue rigidity, contributing factors that increase tissue rigidity, and mechanisms that promote tumor growth initiated by increased tissue rigidity. Various factors lead to i...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2020.1802474

    authors: Zakaria MA,Rajab NF,Chua EW,Selvarajah GT,Masre SF

    更新日期:2020-09-01 00:00:00

  • Local delivery of IL-1 alpha polymeric microspheres for the immunotherapy of an experimental fibrosarcoma.

    abstract::The immunotherapeutic effects of interleukin-1 alpha (IL-1 alpha) encapsulated within 1-5 microns-diameter poly (D, L-lactide) microspheres and delivered intratumorally into fibrosarcoma-bearing mice were investigated. Such microspheres are avidly taken up by macrophages, and directing IL-1 alpha into these cells may ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120023770

    authors: Mullerad J,Cohen S,Benharroch D,Apte RN

    更新日期:2003-01-01 00:00:00

  • Single-dose granulocyte colony-stimulating factor concomitant with multifractionated dose chemotherapy: a strategy for maintaining dose intensity.

    abstract::Multifractionated dosing (MFD) schedules for chemotherapy administration such as weekly or twice weekly administration are intended to maximize dose intensity while minimizing toxicity, but the cumulative drug effect may result in neutropenia necessitating interruption of dose fractions and thereby compromising dose i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909909032865

    authors: Lokich J

    更新日期:1999-01-01 00:00:00

  • Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium.

    abstract::Patients with metastatic prostate cancer resistant to hormones and docetaxel were treated with vinflunine (320 mg/m(2) every 21 days), a new vinca alkaloid with improved preclinical activity. Only 1 of 36 patients (3%) had partial response; the median progression-free survival (PFS) was 2.1 months. Treatment was well ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.3109/07357900902918460

    authors: Hainsworth JD,Meluch AA,Lane CM,Spigel DR,Burris HA 3rd,Gandhi JG,Crane EJ,Stipanov MA,Greco FA

    更新日期:2010-03-01 00:00:00

  • Interventional procedures for cancer pain management: when are they indicated?

    abstract::Non-invasive pharmacological management of patients with cancer related pain has resulted in pain control in 90-95% of the patients. Thus, 5-10% of patients still experience inadequate pain control despite aggressive combined pharmacological therapy. Moreover, patients may not tolerate an aggressive program of titrati...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200027166

    authors: de Leon-Casasola OA

    更新日期:2004-01-01 00:00:00

  • Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.

    abstract::Soft tissue sarcomas are generally resistant to most chemotherapeutic agents, and individuals with advanced disease have a poor prognosis. We evaluated amonafide, a new drug that has significant activity against several tumor cell lines, to determine its activity against sarcomas. Amonafide was administered to 18 pati...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.3109/07357909409038230

    authors: Buys SS,Metch B,Balcerzak SP,Neefe JR,Stuckey WJ

    更新日期:1994-01-01 00:00:00

  • Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients.

    abstract::Gefitinib (ZD1839, Iressa), a member of the 4-anilinoquinazoline class of compounds, has the chemical name 4-quinazolinamine, N-(3-chloro-4-flurophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]. Gefitinib often is referred to as a "specific" or "selective" inhibitor of epidermal growth factor receptor (EGFR). EGFR expre...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900600632058

    authors: Freeman BB 3rd,Daw NC,Geyer JR,Furman WL,Stewart CF

    更新日期:2006-04-01 00:00:00

  • Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values.

    abstract::Pancreatic cancer is the fourth leading cause of cancer death with a 5-year survival less than 5 percent despite rigorous interventions. This largely is due to its late presentation, aggressive metastasis, and a lack of effective adjuvant therapies. Cytokines have been studied in many tumor types, where they have been...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900600981398

    authors: Feurino LW,Fisher WE,Bharadwaj U,Yao Q,Chen C,Li M

    更新日期:2006-11-01 00:00:00

  • Rat PSP94 inhibits the growth and viability of the rat adenocarcinoma cell line PAIII in vitro.

    abstract::Previous studies have shown that human PSP94 can inhibit the growth of prostate cancer cells both in vitro and in vivo. To further validate this potential and investigate the protein within a homologous setting, we examined the effects of rat PSP94 on the growth of the rat prostate adenocarcinoma cell line PAIII in vi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900600629575

    authors: Cadieux PA,Mikolajczak SA,Reeves J,Strathdee C,Reid G,Panchal CJ,Clarke MW

    更新日期:2006-04-01 00:00:00

  • ZBTB7 overexpression contributes to malignancy in breast cancer.

    abstract::ZBTB7 was recently recognized as a proto-oncogene. We studied its prognostic value and relationship to clinicopathological variables in 125 breast cancer patients. ZBTB7 expression was significantly higher in breast cancer tissues than in normal breast tissues, but its gene amplification copies were relatively low. ZB...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357901003631007

    authors: Qu H,Qu D,Chen F,Zhang Z,Liu B,Liu H

    更新日期:2010-07-01 00:00:00

  • Leukemic stem cells: a review.

    abstract::A small subset of cells in a patient with leukemia, termed leukemic stem cells (LSCs) have been shown to be responsible for the proliferation of disease. LSCs are thought to derive from normal hematopoietic stem cells, but are phenotypically distinguishable in that they are CD90(-), CD117(-), and CD123(+). Research in...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2012.700986

    authors: O'Brien JA,Rizzieri DA

    更新日期:2013-05-01 00:00:00

  • Triple-negative breast cancer: unique biology and its management.

    abstract::Triple-negative breast cancer is defined by the lack of expression of estrogen-receptor, progesterone-receptor, and HER-2/neu. It primarily, but not exclusively, carries the basal-like molecular profile on gene expression arrays and is associated with BRCA-1 and p53 mutations. It has an aggressive behavior and predile...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2010.483507

    authors: Maegawa RO,Tang SC

    更新日期:2010-10-01 00:00:00

  • An analog of withaferin A activates the MAPK and glutathione "stress" pathways and inhibits pancreatic cancer cell proliferation.

    abstract::Withaferin A (WA) (1) and two analogs [4-epi-withaferin A (2) and 4,27-diacetyl-4-epi-withaferin A (3)] were evaluated for antitumor activity in pancreatic cancer cells. IC(50) for 1, 2, and 3 were 0.87, 0.45, and 0.29 ?M (BxPC-3); 1.28, 1.53, and 0.52 ?M (MIAPaCa-2); and 0.59, 2.25, and 0.56 ?M (PANC-1), respectively...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.626478

    authors: Liu X,Qi W,Cooke LS,Kithsiri Wijeratne EM,Xu YM,Marron MT,Leslie Gunatilaka AA,Mahadevan D

    更新日期:2011-12-01 00:00:00

  • Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells.

    abstract::A series of 3-aryl/hetarylquinoxaline-2-carbonitrile-1,4-dioxides was synthesized and evaluated against breast cancer cell lines in normoxia and hypoxia. Selected compounds in this series demonstrated better cytotoxicity and comparable hypoxia selectivity than tirapazamine. In contrast to Dox, quinoxaline-1,4-dioxides...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2018.1453072

    authors: Scherbakov AM,Borunov AM,Buravchenko GI,Andreeva OE,Kudryavtsev IA,Dezhenkova LG,Shchekotikhin AE

    更新日期:2018-03-16 00:00:00